Have a personal or library account? Click to login
Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis Cover

Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis

Pneumologia
Volume 70 (2021): Issue 3 (October 2021)
By: Ionela-Alina Grosu-Creangă,  Antigona Carmen Trofor,  Radu Adrian Crișan-Dabija,  Daniela Robu-Popa,  Cristina Mihaela Ghiciuc and  Elena Cătălina Lupușoru  
Open Access
|Oct 2022
DOI: https://doi.org/10.2478/pneum-2022-0029 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Journal RSS Feed
Language: English
Page range: 117 - 126
Published on: Oct 21, 2022
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Keywords:
DR-TB,
second-line drugs,
adverse drug effects
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Pneumology,
Clinical medicine, other

© 2022 Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc, Elena Cătălina Lupușoru, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 70 (2021): Issue 3 (October 2021)Next article